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Background: The spleen is thought to be central in regulating the immune system, a metabolic asset involved
in endocrine function. Overwhelming postsplenectomy infection leads to a mortality rate of up to 50%.
However, there is still controversy on performing subtotal splenectomy as treatment of splenomegaly due to
portal hypertension in cirrhotic patients. In the present study, immunocytes and the indexes of splenic size,
hemodynamics, hematology and immunology in the residual spleen were analyzed to support subtotal
splenectomy due to splenomegaly.
Results: In residual spleen, T lymphocytes mainly were focal aggregation in the periarterial lymphatic sheath. While B
lymphocytes densely distributed in splenic corpuscle. In red pulp, macrophages were equally distributed in the
xsplenic cord and adhered to the wall of splenic sinus with high density. The number of unit area T and B lymphocytes
of splenic corpuscle and marginal zone as well as macrophages of red pulp were obviously increased in the residual
spleen, while the number of macrophages didn’t be changed among the three groups in white pulp. While there were
some beneficial changes (i.e., Counts of platelet and leucocyte as well as serum proportion of CD3+ T cells, CD4+ T
cells, CD8+ T cells were increased markedly; serum levels of M-CSF and GM-CSF were decreased significantly; The
proportion of granulocyte, erythrocyte, megakaryocyte in bone marrow were changed obviously; But serum IgA,
IgM, IgG, Tuftsin level, there was no significant difference; splenic artery flow volume, portal venous diameter
and portal venous flow volume, a significant difference was observed in residual spleen) in the clinical indices.
Conclusion: After subtotal splenectomy with splenomegaly due to portal hypertension in cirrhotic patients, the
number of unit area T and B lymphocytes, and MØ in red pulp of residual spleen increased significantly.
However, whether increase of T, B lymphocytes and MØs in residual splenic tissue can enhance the immune
function of the spleen, still need further research to confirm.
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The spleen is thought to be central in regulating the im-
mune system, a metabolic asset involved in endocrine func-
tion [1]. Overwhelming postsplenectomy infection leads to
a mortality rate of up to 50% [2]. How to reduce infectious
incidence, maintain splenic immune function or conduct
vaccination becomes a hot issue of innovation for surgeons* Correspondence: xiaojizhu@163.com
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unless otherwise stated.[3,4]. Bierring et al [5] first reported the study about sub-
total splenectomy carried out on the rats. Morgenstern
et al [6] applied this surgical method in clinical prac-
tice. Later, a series of research has proven that approxi-
mately 25% of the residual splenic tissue can protect
against pneumonococcus [7]. Phagocytic function of
the splenic remnant after subtotal splenectomy was
maintained, and the amounts of T, B cells remained indis-
tinguishable from those in normal circumstances. In con-
trast, the phagocytic function of the splenic remnant after
autotransplantation decreased, autotransplanted splenic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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and T lymphocytes with widespread loss of follicles and
periarterial lymphatic sheath (PALS) [8,9]. Clinical prac-
tice shows that subtotal splenectomy applies to splenic in-
juries, splenomegaly for hematological diseases and portal
hypertension [10-12].
There is still controversy on performing subtotal
splenectomy as treatment of splenomegaly due to por-
tal hypertension in cirrhotic patients. Advocates for
splenectomy believe that, with fibrosis and little im-
mune function in splenomegaly, recurrence of spleno-
megaly and hypersplenism may happen in residual
spleen [13]. However, advocates inclined to preserve
spleen argue that subtotal splenectomy may reduce
portal venous pressure, correct hypersplenism and retain
the immune function of spleen—which means killing two
birds with one stone [14]. Subtotal splenectomy includes
two ways, i.e., with preserving the upper pole and the
lower pole of the spleen supplied by the gastrosplenic
vessels, spleno-omental and spleno-coloic vessels [14,15].
In the present study, immunocytes and the indexes of
splenic size, hemodynamics, hematology and immunology
in the residual spleen were analyzed to support subtotal
splenectomy due to splenomegaly in cirrhotic patients.
Results
Spleen organization were obtained by operating formed
splenomegaly group. Patients who had spleen puncture
to check for spleen organization 8 years after surgery
formed the residual spleen group. Patients who under-
went splenectomy but who did not have splenomegaly
formed the control group.
In residual spleen group, T lymphocytes mainly were
focal aggregation in the periarterial lymphatic sheath
(PALS), and sporadic or focal distribution in red pulp.
while B lymphocytes densely distributed in splenic cor-
puscle, but was sporadic in red pulp, and its volume was
slightly smaller, and dyed deeply (Figure 1A, B). In the
splenomegaly group, splenic corpuscular atrophy, PALS
narrowed, and their number decreased, splenic sinus
stenosis and stasis, splenic cord thickened, densely dis-
tribution area of T cells zone reduced, density of B cell
around the splenic corpuscular decreased, and B cells in
red pulp is slightly less, T and B lymphocytes increased
in size, staining lightly (Figure 1C, D). In the control
group, T cells densely distributed in PALS, sparsely in
red pulp (Figure 1E), B cells were densely distributed in
splenic corpuscle, and were scattered in red pulp (Figure 1F).
In the residual spleen group, MØs well-distributed in
the splenic cord and adhered to the wall of splenic sinus
in red pulp, with high density and dying deeply. In white
pulp, MØs were scattered in splenic corpuscle, and were
concentrated obviously in MZ, and may see larger MØ
(Figure 1G, H). In the splenomegaly group, MØs in thered pulp distributed loosely and irregularly, density obvi-
ously lower, understained in color, distribution of MØs
in splenic corpuscular and MZ of white pulp was the
same as residual spleen (Figure 1I, J). In the control
group, MØs equally distributed in splenic cord and ad-
hered to the wall of splenic sinus in red pulp, with high
density and dying deeply; distribution of MØs in splenic
corpuscular and MZ of white pulp was the same as re-
sidual spleen (Figure 1K, L).
Residual spleen was preserved about 11 × 7 × 4 cm on
operation. It was alive that was confirmed by CT scan, and
still had phagocytosis via splenic scintigraphy with 99mTc
sulfur colloid after eight years (Figure 2A-E).
Quantitative analysis of T, B lymphocytes, MØs
For T and B lymphocytes, significant differences in re-
sidual spleen group as compared with splenomegaly
group and control group were observed (p < 0.05), and a
significant difference was also observed between spleno-
megaly group and congtrol group (p < 0.05) (Table 1).
In red pulp, significantly higher the counts of MØs in
the residual spleen group as compared with splenomeg-
aly group and control group was observed (p < 0.05). A
significant difference between splenomegaly group and
control group was also seen (p < 0.05). However, signifi-
cant difference was not observed among the three
groups in white pulp (splenic corpuscle and MZ) (p > 0.05)
(Table 2).
Change of splenic size, hemodynamics, hematological,
immunological indices between residual spleen and
splenomegaly
With respect to splenic length, splenic thickness, splenic
square area, splenic artery flow volume, portal venous
diameter and portal venous flow volume, a significant
difference was observed between residual spleen groups
and splenomegaly groups (p < 0.001). Counts of platelet
and leucocyte in residual spleen were increased mark-
edly compared with splenomegaly groups, and a signifi-
cant difference was observed (p < 0.001). With respect to
IgA, IgM, IgG, Tuftsin level, there was no significant dif-
ference between residual spleen groups and splenomeg-
aly groups (p > 0.05) (Table 3).
Change of serum proportion of CD3+ T cells, CD4+ T
cells, CD8+ T cells, serum levels of M-CSF and GM-CSF as
well as the proportion of granulocyte, erythrocyte,
megakaryocyte in bone-marrow indices between residual
spleen and splenomegaly
Serum proportion of CD3+ T cells, CD4+ T cells, CD8+ T
cells were in residual spleen increased markedly compared
with splenomegaly groups, and a significant difference
was observed (p < 0.05) (Table 4). Serum levels of M-CSF
and GM-CSF were decreased significantly, there was a
Figure 1 Immunohistochemical staining of T, B lymphocytes and macrophages (MØs) in residual spleen , splenomegaly and normal
spleen. (A). Identification of T lymphocytes in PALS of residual spleen. (B). T lymphocytes in PALS of splenomegaly. (C). T lymphocytes in PALS of
normal spleen (A-C, immunohistochemistry for CD45RO, ×400 magnification. Bars, 50 μm). (D). B lymphocytes in the splenic corpuscle and red
pulp of residual spleen. (E). B lymphocytes in the splenic corpuscle and red pulp of splenomegaly. (F). B lymphocytes in the splenic corpuscle
and red pulp of normal spleen (D-F, immunohistochemistry for CD20, ×400 magnification. Bars, 50 μm). (G). Identification of MØs in splenic cords
and sinuses wall of residual spleen. (H). MØs in splenic corpuscle and MZ of residual spleen. (I). MØs in splenic cords and sinuses wall of
splenomegaly. (J). MØs in splenic corpuscle and MZ of splenomegaly. (K). MØs in splenic cords and sinuses wall of normal spleen. (L). MØs in
splenic corpuscle and MZ of normal spleen (G-L, immunohistochemistry for CD68, ×400 magnification. Bars, 50 μm).
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splenomegaly groups (p < 0.05) (Table 5). The proportion
of granulocyte, erythrocyte, megakaryocyte in bone mar-
row were changed obviously, and a significant difference
was seen (p < 0.05 and p < 0.01, p < 0.001 or p > 0.05)
(Table 6).
Discussion
The spleen is a highly compartimentalized organ, and
each compartment has its own structure, cell population,
and functions [16]. White pulp PALS contains a large
number of T lymphocytes, red pulp reticular meshwork
contains MØs and abundant erythrocytes, and MZ is di-
vided into an inner and an outer compartment by a spe-
cial type of fibroblasts, in which a variety of cell typesare combined, such as different types MØs at the inner
border, and to a lesser extent, the MZ B cells. For other
cell types-T lymphocytes, small B cells, and dendritic
cells–the MZ is only a temporary residence [17,18]. The
splenic compartments show different kinetics for migrat-
ing lymphocytes [19]. Splenic MZ is the pathway of T
and B lymphocytes migration, and contains accessory
cells (MZ macrophages and interdigitating cells) associ-
ated with cell migration [20,21]. It has been reported that
the splenic MZ MØ population has its special function,
controlling the retention and trafficking of B lymphocytes,
and interacts with apoptotic material entering the spleen
from circulation to minimize the immunogenicity of auto-
antigens [22,23]. MØs display remarkable plasticity and
can change their physiology in response to environmental
Figure 2 Images of clinical data. (A&B). CT images of preoperative and postoperative eight years. (C&D). Intraoperative splenomegaly and
residual spleen. (E). Splenic scintigraphy with 99mTc sulfur colloid after eight years (residual, arrow).
Table 2 Macrophage counts in splenic tissue (n = 13,
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tions of cells with distinct function [24]. It can be seen
that the splenic white pulp and MZ were is a gathering
area of mass T , B lymphocytes and specific functional
MØs , the core parts of the splenic immune function was
called, and its range was depended the number and func-
tions of T, B lymphocytes, and MØs, so it becomes the
portal of the splenic immune function.
When splenomegaly, there was hyperplasia and hyperac-
tivation of the splenic lymphoid tissue, and CD4+/CD8+ T
cell ratios increased, the proportion of CD8+ T cells de-
creased, immature B cells or immunoblasts will proliferate
in response to antigenic stimuli [25,26]. Yamamoto and Li
et al. reported that the volume of red pulp of the spleen
with portal hypertension was increased in a unit area, the
white pulp was scanty of T and B lymphocytes and de-
creased in a unit area, but it was increased in the
whole spleen. Although proliferation and distribution
may be disordered, they believe that the spleen with
portal hypertension may still have immune function
[27,28]. Animal experiments in rabbits and mice,
Histological study showed both the total number of
cells and the number of cells per gram of tissue were sig-
nificantly reduced, and antibody response was poorly inTable 1 Number of T and B Lymphocytes in Splenic
Tissue (n = 13, means ± SD)
T Lymphocytes B Lymphocytes
(per 10–5 pixel area) (per 10–5 pixel area)
Residual spleen 59.77 ± 9.43a 10.82 ± 1.94a
Splenomegaly 34.72 ± 3.50b 2.37 ± 0.66b
Control 48.23 ± 14.87 6.84 ± 0.81
Compared with the splenomegaly and control group, aP < 0.05; compared with
the control group, bP < 0.05.autotransplantation after splenectomy. There was a sub-
stantial reduction in the percentage of some of the cells
examined (CD4+ and CD8+ T lymphocytes subsets), but
not all (B lymphocytes, ED1+ and ED2+ macrophages,
OX2+ and OX6+ cells). This results suggests that the re-
generated spleen can maintain T cell number, but cannot
compensate for the immunological function of the original
one,especially host resistance to infection [29,30]. Li et al.
reported the relative quantity of MØs per unit weight of
splenomegaly decreased significantly, however, total quan-
tity of MØs increased significantly, so rhe results suspect
the latter was relatively increased due to enlargement of
splenic volume [31]. Whereafter found that the phagocyt-
osis rate and phagocytic capacity of MØ in splenomegaly
was more higher than the control group, nevertheless this
prompt that macrophage phagocytosis may be positively
correlated with the degree of hypersplenism [32]. A group
of researchers show that, in the patients of splenomegaly
with immune thrombocytopenia,the phagocytosis rate in
splenic macrophages positively correlated with the ratio of
Th1/Th2, but negatively correlated with percentage of
Th2 cells [33]. Thus, splenomegaly and hyperdynamicmeans ± SD)
Macrophage counts
Rep Pulp (per 10–5 pixel
area)




31.09 ± 9.73a 16.69 ± 4.37
Splenomegaly 4.20 ± 0.88b 15.77 ± 5.00
Control 7.46 ± 0.86 14.46 ± 2.90
Compared with the splenomegaly and control group, aP < 0.05; compared with
the control group, bP < 0.05.
Table 3 Comparison of splenic size, hemodynamic,
hematological and immunological indices between the




Splenic length (cm) 47.77 ± 4.85 11.31 ± 1.11 <0.01
Splenic thickness (cm) 10.00 ± 1.68 3.62 ± 0.51 <0.01
Splenic square area (cm2) 387.20 ± 101.09 33.05 ± 7.31 <0.01
Splenic artery flow
volume (ml/kg.min)
7.51 ± 0.56 2.91 ± 0.03 <0.01
Portal venous
diameter (cm)
1.42 ± 0.04 1.15 ± 0.04 <0.01
Portal venous flow
volume (ml/kg.min)
19.72 ± 0.37 16.46 ± 0.37 <0.01
Leucocytes (×109/L) 2320.77 ± 322.22 4261.54 ± 276.07 <0.01
Platelets (×109/L) 51.30 ± 5.98 218.77 ± 28.69 <0.01
IgA (g/L) 4.14 ± 0.34 4.34 ± 0.07 >0.05
IgM (g/L) 3.04 ± 0.21 3.15 ± 0.10 >0.05
IgG (g/L) 20.15 ± 1.32 21.21 ± 1.40 >0.05
Tuftsin (μg/L) 603 ± 162 656 ± 147 >0.05
Table 5 Comparison of serum levels of M-CSF and GM-
CSF between the two groups (n = 13, ng/ml, means ± SD)
Splenomegaly Residual spleen P value
M-CSF 3.19 ± 0.19 1.86 ± 0.18 <0.001
GM-CSF 2.07 ± 0.18 0.39 ± 0.10 <0.001
Table 6 Comparison of the proportion of granulocyte,
erythrocyte, megakaryocyte in bone marrow between the




Myeloblast 0.38 ± 0.04 0.35 ± 0.03 >0.05
Promyelocyte 1.60 ± 0.12 1.70 ± 0.15 >0.05
Neutrophilic myelocyte 6.62 ± 0.61 7.84 ± 0.59 <0.001
Neutrophilic metamyelocyte 9.11 ± 0.81 12.81 ± 0.56 <0.001
Stabnuclear neutrophil 15.52 ± 1.28 18.38 ± 0.48 <0.001
Neutrophilic granulocyte
segmented form
6.57 ± 1.18 16.17 ± 1.27 <0.001
Eosinophile granulocyte
(per stage)
6.06 ± 1.43 7.26 ± 1.86 >0.05
Basophilic leukocyte (per stage) 0.04 ± 0.03 0.22 ± 0.18 >0.05
Macroblast of Naegeli 0.67 ± 0.13 0.30 ± 0.07 <0.001
Basophilic erythroblast 1.99 ± 0.17 0.79 ± 0.84 <0.001
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of T and B lymphocytes as well as MØs in unit area or
volume decreased. This finding suggested that splenic
tissue structure is closely correlated with the quantity
of T, B lymphocytes and MØs, while whether remodel-
ing of these cells would affect the splenic immune
function still remained controversy.
In this present study, the histological features of the re-
sidual spleens which were reserved was discovered as fol-
lows: Firstly, the size of the residual spleen was similar to
normal. Secondly, the number of splenic corpuscle and
PALS increased, the morphous of the splenic sinus ap-
proximated to normal, structure compact. Thirdly, T lym-
phocytes shaped focal aggregation in the PALS. Fourthly,
B lymphocytes densely distributed in splenic corpuscle.
Fifthly, MØs were evenly distributed in the splenic cord
and adhered to the wall of splenic sinus in red pulp, in-
creased density and dyed deeply, they were diffused distri-
bution in splenic corpuscle of white pulp, and more
densely distributed in MZ, with larger cell volume. Quan-
titative analysis of the cells showed that Significantly
higher counts of unit area T and B lymphocytes in the
residual spleen group obviously increased as comparedTable 4 Comparison of serum proportion of CD3 + T
cells, CD4 + T cells, CD8 + T cells between the two
groups (n = 13,%, means ± SD)
Splenomegaly Residual spleen P value
CD3+ T cells 56.20 ± 2.90 65.68 ± 2.30 <0.001
CD4+ T cells 32.90 ± 2.30 40.00 ± 2.90 <0.001
CD8+ T cells 3.26 ± 0.20 24.60 ± 2.40 <0.001with splenomegaly group and control group, while
splenomegaly group significantly decreased than con-
trol group. Significantly higher number of unit area
MØs of red pulp in the residual spleen group obviously
increased as compared with splenomegaly group and
control group, but splenomegaly group significantly
less than control group. In addition, hemodynamics of
the residual spleen and portal vein improved, amounts
of platelet and leucocyte rose to normal, and there
were no significant changes in immunological indexes.
Results suggest that subtotal splenectomy may reduce
portal venous pressure, correct hypersplenism and re-
tain immune function of spleen. Our study demon-
strated that the distribution characteristics of MØ in
red pulp resembles Vasco’s report [34]. MZ MØs are lar-
ger and morphologically distinct from other macrophages
[35,36]. Our results suggest that high hemodynamic bood
plays an crucial and initial role in adaptive changes of
splenomegaly tissue. Splenic histological remodeling must
be involed in migration and redistribution of cells, whenPolychromatophilic erythroblast 20.15 ± 1.37 5.81 ± 2.27 <0.001
Acidophilic normoblast 13.11 ± 2.43 7.11 ± 1.93 <0.001
Megakaryoblast 0.44 ± 0.17 0 <0.001
Immature megakaryoblast 2.47 ± 1.83 0.20 ± 0.05 <0.001
Granula megakaryoblast 61.56 ± 5.85 22.88 ± 1.59 <0.001
Maturity form megakaryoblast 26.32 ± 2.56 71.13 ± 3.73 <0.001
Naked nucleus 7.97 ± 5.32 4.66 ± 5.25 >0.05
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of T and B lymphocytes per unit area in their respective
function zone of residual spleen increased, that may en-
hance the ability of immune response in the residual
spleen. MØ accumulation remodeling in red pulp of
the residual spleen indrectly reflected that hematopoietic
function of red pulp enhanced. Splenic marginal zone was
the pathway through which lymphocytes migrated from
the white pulp into red pulp, where lymphocytes closely
contacted with MØs and interdigitating cells, and partici-
pated in the immune response after being activated
[21,37]. There was no significant difference in counts
of MØs in white pulp and MZ among the three
groups, indicating that number of MØ involved in im-
mune response didn’t decrease due to fibrosis in groups of
residual spleen and splenomegaly. Besides, after subtotal
splenectomy with splenomegaly due to portal hypertension
in cirrhotic patients, serum proportion of CD3+ T cells,
CD4+ T cells, CD8+ T cells were increased markedly and
serum levels of M-CSF and GM-CSF were decreased sig-
nificantly. Results suggest that residual splenic tissue can
enhance immune reaction and weaken inflammatory reac-
tion. The proportion of granulocyte, erythrocyte, megakar-
yocyte in bone marrow were changed obviously. Results
suggest that the spleen inhibited the bone marrow, and
haemocyte function was removed. Our previous study
found that there was no significant difference in the con-
tent of collagen, elasticity and reticular fiber between the
residual spleen and splenomegaly. The ultra cell structure
of the residual spleen was similar to that in normal spleen,
suggesting fibrosis presented and cell morphology was nor-
mal in residual spleen. The change of immune cells and
heamodynamic, hematological and immunological indices
proves that it is feasible and necessary to implement sub-
total splenomegaly for portal hypertension. We believe that
the residual spleen has its special artery blood-supply,
maintaining the tissue structure and cell function of the
spleen on one hand, and improving the status of high-
pressure and hypoxia in the spleen on the other hand. Rec-
tification of hypersplenism, extrication from high-pressure
and cease of fibrosis in spleen was all conducive to accu-
mulation, growth and performance of immune function of
T, B lymphocytes and MØs in white pulp and MZ of the
spleen. These discoveries of ours have considerable clinical
guiding significance for deciding between “exsect” and “re-
serve” for splenomegaly due to portal hypertension. Cores
function of the spleen is immune function, and alteration
of immunocytes in residual spleen can reveal regularity of
inherent function in fibrosis spleen. However, whether in-
crease of T, B lymphocytes and MØs in residual splenic tis-
sue can enhance the immune function of the spleen, still
need further research to confirm. Because our sample size
was small, a multi-centre large-sample study is needed.
Nevertheless, this study provided interesting information:after subtotal splenectomy with splenomegaly due to portal
hypertension in cirrhotic patients, the residual spleen still
has immune function.Conclusions
Subtotal splenectomy for splenomegaly due to portal
hypertension results in a significant increase in the num-
ber per unit area of T cells and B cells, and in the num-
ber of macrophages in red pulp of the residual spleen.Methods
Ethical approval of the study protocol (No. 5986) was
approved by the Human Research Ethics Committee of
the Weifang Medical University. All individuals provided
written informed consent before being included in the
study.Study population
Our studies relating to subtotal splenectomy started in
1984. Up to 2012, we have conducted 752 operations of
subtotal splenectomy (preserving the lower pole, normal
spleen size of splenic tissue, splenic omentum and sple-
nocolic vessels for the purpose of blood-supply), with
117 cases for splenic trauma and 635 for splenomegaly
due to portal hypertension. Thirteen tissue samples
were collected from patients in the 89th Hospital of
the People’s Liberation Army (Weifang, China). thirteen
cases (7 males and 6 females; mean age, 31 (26–36) years))
with splenomegaly due to portal hypertension who had re-
ceived subtotal splenectomy plus fixation of the posterior
sternal omentum majus were included in this group. Pa-
tients were confirmed to have cirrhosis after hepatitis-B
infection, HBV-DNA was negative and were classified as
class A or B according to the Child–Pugh classification.
Cirrhosis was accompanied by hypersplenism with light or
moderate varicose veins of the lower esophagus, and the
fibrosis level in the spleen was III. Color Doppler ultra-
sound was used before surgery and 8 years after sur-
gery to measure the size of the spleen. The preoperative
long-diamater was 48 ± 5 cm, the transverse diameter was
30 ± 4 cm, and the pachy- diamater was 10 ± 2 cm. The
postoperative long-diameter was 11 ± 1 cm, the trans-
verse diameter was 7 ± 1 cm, and the pachy-diameter
was 4 ± 1 cm. Spleen organization were obtained by
operating formed splenomegaly group. Patients who
had spleen puncture to check for spleen organization
8 years after surgery formed the residual spleen group.
Thirteen cases (7 males 6 females; mean age, 30 (28–37)
years) who underwent splenectomy but who did not have
splenomegaly formed the control group. Guided by color
Doppler ultrasound, hollow-needle biopsy was used for to
obtain samples of residual splenic tissue [38].
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Thirty nine tissue samples were collected. Specimens were
fixed in 10% formalin, dehydrated, embedded and sliced.
Each specimen was made into 15 slices (5 slices per
group). PH 8.5, EDTA antigen retrieval, 3% peroxide-
methano and goat serum closed by SP immunohistochem-
ical method. CD45RO antibody (Sunbio, Shanghai, China)
was used to specifically stain T-cells, and CD20 antibody
(Sunbio) was used to identify B-cells, whereas CD68 anti-
body (Sunbio) was used to identify macrophages (MØs).
Samples were then diluted in phosphate-buffered saline
(PBS) and colored with 3,3-diaminobenzidine (DAB). De-
hydration, clearing, and mounting with neutral gums was
carried out. A negative control group was obtained using
the same steps as described above, but instead the anti-
body was replaced by PBS. After staining, slices were ob-
served under a light microscope (BX51; Olympus, Tokyo,
Japan) for histomorphological analyses. Under light micro-
scope (×400), Image-Pro Plus (Media Cybernetics, Silver
Spring, MD) was used to calculate the the counts of T, B
lymphocytes and MØs, respectively. Three effective
visual field of each section were selected, calculated
the counts of positive T, B lymphocytes per pixel area
in aim area, and then counted the mean (pixel density
was 2.88 pixels/μm) [39,40]. Selection criteria of meas-
uring region: T lymphocytes’ measurement area was
PALS, and B lymphocytes’ measurement area, includ-
ing marginal zone (MZ) and part of red pulp. And the
measuring region of MØs included red pulp and the
splenic corpuscular and MZ of white pulp.
In addition, patients underwent complete physical exam-
ination before and after the operation, which included
abdominal ultrasonography (splenic size: splenic length,
splenic thickness, splenic square area; hemodynamics:
splenic artery flow volume, portal venous diameter, portal
venous flow volume), abdominal CT scan, splenic scintig-
raphy with 99mTc sulfur colloid, laboratory hematological
(platelets, leucocytes) immunological (serum IgA, IgM,
IgG, Tuftsin, CD3+ T cells, CD4+ T cells, CD8+ T cells,
M-CSF, GM-CSF) and bone-marrow evaluation.Statistical analyses
Data analyses were carried out using SPSS 17.0 (SPSS
Inc., Chicago, Illinois). All values are means ± standard de-
viation (SD). Groups were compared by the t-test. P < 0.05
was considered significant.
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